Skip to main content
. Author manuscript; available in PMC: 2024 Sep 3.
Published in final edited form as: AIDS Res Hum Retroviruses. 2023 Mar 22;39(10):525–532. doi: 10.1089/AID.2022.0149

FIG. 1.

FIG. 1.

Cumulative incidence of LTFU among patients: adults receiving ART through CASG support (i.e., ever in a CASG) (yellow line) and adults receiving ART who were not ever in a CASG (i.e., eligible for, but never in a CASG) (blue line). ART, antiretroviral therapy; CASG, community adherence support group; LTFU, loss to follow-up.